NASDAQ · LAKEHealthcareOrthopedic & Surgical Supplies

Lakeland Industries financials

$10.39+1.17%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY26
Jan 31
FY25
Jan 31
FY24
Jan 31
FY23
Jan 31
FY22
Jan 31
FY21
Jan 31
FY20
Jan 31
FY19
Jan 31
FY18
Jan 31
FY17
Jan 31
Revenue$192.6M$167.2M$124.7M$112.8M$118.4M$159.0M$107.8M$99.0M$96.0M$86.2M
Gross profit$63.3M$68.7M$51.2M$45.8M$50.9M$79.3M$37.9M$33.9M$36.2M$31.6M
Gross margin32.9%41.1%41.1%40.6%43.0%49.9%35.2%34.2%37.7%36.7%
Operating income-$19.8M-$9.3M$6.0M$5.5M$16.0M$43.9M$5.9M$3.6M$8.5M$6.8M
Net income-$25.3M-$18.1M$5.4M$1.9M$11.4M$35.3M$3.3M$1.5M$440.0K$3.9M
Net margin−13.1%−10.8%4.4%1.7%9.6%22.2%3.0%1.5%0.5%4.5%
Diluted EPS$-2.63$-2.43$0.72$0.24$1.41$4.34$0.41$0.18$0.06$0.53
EBITDA-$8.6M$4.6M$8.1M$7.0M$17.9M$45.9M$7.5M$4.5M$9.3M$8.0M
Operating cash flow-$15.8M-$15.9M$10.9M-$5.5M$12.8M$40.7M$3.6M$1.8M$648.0K$11.5M
Free cash flow-$16.4M-$17.4M$8.8M-$7.4M$12.0M$39.0M$2.6M-$1.3M-$257.0K$11.1M
Diluted shares9.6M7.4M7.5M7.7M8.1M8.1M8.0M8.2M7.7M7.3M

Balance sheet

Period endJan 31Jan 31Jan 31Jan 31Jan 31Jan 31
Cash & equivalents$12.5M$17.5M$25.2M$24.6M$52.7M$52.6M
Short-term investments$0.00$0.00$0.00$0.00——
Total debt$32.3M$17.4M$1.0M$405.0K$0.00$0.00
Total assets$209.9M$212.5M$153.7M$142.9M$140.8M$139.6M
Total liabilities$80.8M$65.9M$30.3M$22.9M$15.7M$17.8M
Shareholders' equity$129.1M$146.6M$123.5M$120.0M$125.1M$121.8M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology